A recent client presentation on our ClarityNav platform illustrated just how far AI has come. Our platform ingests large volumes of multimodal sources of voice of customer data, such as unstructured conversations. Trained using a brand’s strategic imperatives and strategically human-developed key business questions, ClarityNav can process thousands of rows of unstructured data in seconds to identify key themes. In recent client cases, it has demonstrated up to 80% time savings, reducing data integration efforts from 40 hours a month to just 8.
From these insights our strategists collaborate with clients to recommend commercial actions such as changes to patient or HCP content, how therapeutic brands need to better support office workflow, or insights to competitive products being raised by customers. Speed in moving from insights to taking action in the market gives clients the competitive advantage.
One client asked “why can’t AI just tell us what actions to take? Why do we need a strategist to explain what actions to take? Isn’t AI smart enough?”. Strategic action requires more than data – it demands a deep understanding of the therapeutic area, competitive landscape, HCP behavior, and the operational context of each organization. It’s through those real-life challenges that only human experts can determine the course of action or how we need to adapt to the market nuances, we are able to recommend actions that have an impact in the market.
We can’t rely on AI to make decisions and in most cases, AI doesn’t possess decades of real-life commercial and medical leadership experience. Human experts are uniquely positioned to navigate these real-world complexities and determine actions that will make a measurable impact. AI, no matter how advanced, cannot replicate decades of commercial and medical leadership experience.
In 2025, it’s clearer than ever: AI is reshaping every industry, including pharmaceutical commercialization. But with this incredible power comes an important reminder: we cannot afford to lose our most essential skills, especially critical thinking.
Recent research by Microsoft and futurist Andrea Clarke highlights Adaptability as the top human skill for the future of work. Adaptability isn’t just about flexibility; it’s about thinking critically, questioning assumptions, making sense of complexity, and adjusting strategies when the world shifts – fast.1,2
In pharmaceutical commercialization, this couldn’t be more true.
AI can segment customers, recommend promotional channels, and predict sales patterns.
But it cannot:
AI can inform. Humans must still decide. That’s why Human-in-the-Loop systems aren’t just “nice to have” – they are essential. Humans must remain engaged, interpreting AI outputs with curiosity, skepticism, and creativity. Our role isn’t to compete with AI; it’s to complement it – bringing judgment, ethics, and critical thought to every decision.
As AI continues to evolve, so must we. Let’s invest not only in better AI tools, but also in stronger human skills. Critical thinking is the ultimate future-proof strategy.
If you’re thinking about how to strengthen critical thinking Therapeutic Area skills in your commercialization teams, how to move faster from insight to action – or how to build smarter Human + AI workflows, contact us.
References:
Jump to a slide with the slide dots.
Explore how MAPS EMEA 2025 redefined Medical Affairs - patient-centricity, AI, evidence generation & launch excellence take center stage
Read moreAI is transforming Health Technology Assessment, but trust, transparency, and clear HTA guidance are key to broader acceptance.
Read moreGLP-1s are redefining cardiometabolic care. Explore key insights, trials, and whitespace from ACC 2025 with ClarityNav analysis.
Read more